{"id":"tropesin","rwe":[{"pmid":"1820177","year":"1991","title":"The influence of some non-steroidal anti-inflammatory drugs on the retraction of collagen lattices.","finding":"","journal":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","studyType":"Clinical Study"},{"pmid":"3907121","year":"1985","title":"[Use of tropesin in the treatment of rheumatoid arthritis].","finding":"","journal":"Vnitrni lekarstvi","studyType":"Clinical Study"},{"pmid":"7083342","year":"1982","title":"[Tropesin metabolites in man].","finding":"","journal":"Ceskoslovenska farmacie","studyType":"Clinical Study"},{"pmid":"7195374","year":"1981","title":"[Effect of indomethacin and tropesin on the release of lysosomal enzymes and cyclic nucleotide levels after phagocytosis of urate and zymosan].","finding":"","journal":"Fysiatricky a reumatologicky vestnik","studyType":"Clinical Study"},{"pmid":"737751","year":"1978","title":"[Indomethacin and substance VUFB 12018 (Tropesin SPOFA). A comparison of their side effects on the gastrointestinal tract of rats].","finding":"","journal":"Ceskoslovenska farmacie","studyType":"Clinical Study"}],"tags":[{"label":"tropesin","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"unknown","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"repanidal","offLabel":[],"synonyms":["tropesin","repanidal"],"timeline":[],"approvals":[],"brandName":"Repanidal","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"tropesin","explanation":"Imagine repanidal as a key that fits into a lock on a cell. When it binds to the lock, it triggers a series of events that ultimately lead to a desired outcome, such as reducing inflammation or blocking a disease-causing process.","oneSentence":"Repanidal works by interacting with a specific molecular target to produce a therapeutic effect.","technicalDetail":"Repanidal's mechanism of action is not well understood, but it is believed to involve the modulation of a specific protein or receptor, leading to changes in cellular signaling pathways and ultimately resulting in a therapeutic effect."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/2773","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=tropesin","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T16:04:59.422180","biosimilars":[],"competitors":[],"genericName":"tropesin","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"P8NV2308A2","CHEBI":"CHEBI:135807","UMLSCUI":"C0147019","PUBCHEM_CID":"47530","MESH_SUPPLEMENTAL_RECORD_UI":"C018791"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":5,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[{"date":"1991","pmid":"1820177","title":"The influence of some non-steroidal anti-inflammatory drugs on the retraction of collagen lattices.","journal":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"date":"1985 Nov","pmid":"3907121","title":"[Use of tropesin in the treatment of rheumatoid arthritis].","journal":"Vnitrni lekarstvi"},{"date":"1982 Mar","pmid":"7083342","title":"[Tropesin metabolites in man].","journal":"Ceskoslovenska farmacie"},{"date":"1981 Apr","pmid":"7195374","title":"[Effect of indomethacin and tropesin on the release of lysosomal enzymes and cyclic nucleotide levels after phagocytosis of urate and zymosan].","journal":"Fysiatricky a reumatologicky vestnik"},{"date":"1978 Sep","pmid":"737751","title":"[Indomethacin and substance VUFB 12018 (Tropesin SPOFA). A comparison of their side effects on the gastrointestinal tract of rats].","journal":"Ceskoslovenska farmacie"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Repanidal (tropesin) is a small molecule drug in the tropesin class, but specific details about its target, mechanism of action, and approved indications are not available. As a result, there is limited information on its commercial status, safety considerations, and pharmacokinetic properties. Further research is needed to understand the clinical utility and potential risks associated with repanidal. The lack of information on its target and mechanism of action suggests that it may be a novel or experimental compound. More data is required to determine its potential as a therapeutic agent.","enrichmentLevel":3,"visitCount":3,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}